The PIP breast implant scandal continues as Health Secretary Andrew Lansley joins experts at the Department of Health to examine whether the NHS should foot the bill for corrective operations.
The Medicines and Healthcare Products Regulatory Action (MHRA) had previously said that they had no safety concerns over the implants, made by French company PIP.
But tests have revealed that PIP substituted medical grade silicone with cheaper industrial grade silicone. Yesterday, an analysis of the implant, commissioned by radio station RTL, showed that the implants contain Baysilone, Silopren and Rhodorsil.
Baysilone is a fuel additive, while Silopren and Rhodorsil and used in the production of rubber tubing. A spokesman for RTL said:
These products "have never been clinically tested for their possible harmful effects on the body."
The MHRA had previously said that the rupture rate of the implants was less than one per cent, but the figure is now estimated to be 7 per cent.
Mr Fatah, president of the British Association of Plastic Surgeons, said all the 40,000 women who have had the implants should have them removed, regardless of their rupture rate.
Tim Goodacre, president of the British Association of Plastic, Reconstructive and Aesthetic Surgeons, said:
"Even with a very low rupture rate, we would want to see most implants removed on a staged basis.”
The Department of Health's position remains that there is "no evidence to make us think that they [women] should have the PIP implants removed" if they have not ruptured.
© ActiveQuote Ltd. 2012